key: cord-0715550-6gmu4dn0
authors: D’Amico, Ferdinando; Peyrin-Biroulet, Laurent; Danese, Silvio
title: Physician-patient communication is key to improve IBD management during COVID-19 pandemic
date: 2021-02-04
journal: Gastroenterology
DOI: 10.1053/j.gastro.2021.02.001
sha: 49564d0f051a3b41cfaf94678c2c89d03c702357
doc_id: 715550
cord_uid: 6gmu4dn0

nan

We thank Chen and colleagues for their letter 1 that shows the association between therapy discontinuation and worsening of symptoms and outcomes (e.g. hospitalization, surgery, and intestinal complications) in patients with inflammatory bowel disease (IBD) during COVID-19 pandemic. In their cohort, 13% of patients had spontaneously discontinued the IBD therapy due to concerns about COVID-19 infection or adverse drug reactions, leading to disease worsening in about a quarter of cases. However, it is not known whether these patients received recommendations regarding therapy from healthcare professionals.

Interestingly, in a recent global survey including nearly 4,000 IBD patients, most of the participants were afraid of contracting SARS-CoV-2 infection and attending the hospital for scheduled follow-up 2 . Additionally, about two-thirds of respondents believed that immunosuppressive drugs were associated with an increased risk of developing COVID-19.

Of note, a 4% voluntary drug discontinuation rate was found and most patients did not want to discontinue current medications. It is important to highlight that about half of the subjects did not receive medical recommendations to prevent the viral infection. Furthermore, among patients who received recommendations, many requested additional clarification, emphasizing the lack of adequate communication between physicians and patients. Proper patient education is essential to minimize patient concerns and ensure a higher rate of treatment adherence. Telemedicine is a valid option to fill the existing gap, but further efforts are needed to improve its acceptance by patients and increase its use in the daily clinical routine 3 .

Moreover, patient associations should be more involved to facilitate the dissemination of appropriate information, to improve adherence to treatments, and to ensure the optimal management of IBD patients.

J o u r n a l P r e -p r o o f

Impact of medication discontinuation on patients with inflammatory bowel disease during the COVID-19 outbreak

Views of patients with inflammatory bowel disease on the COVID-19 pandemic: a global survey

Trust in telemedicine from IBD outpatients during the COVID-19 pandemic